Back to Journals » OncoTargets and Therapy » Volume 8

Original Research

Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair

       
Total article views   HTML views PDF downloads Totals
11,843 Dovepress* 11,044+ 1,868 12,912
PubMed Central* 799 389 1,188
Totals 11,843 2,257 14,100
*Since 25 February 2015
+Since July 2016

View citations on PubMed Central and Google Scholar